New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BX;SVU;ORCL;ACAD;GES;HPQ;SCHL;DELL;CSCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
August 25, 2015
09:35 EDTCSCOActive equity options trading on open
Subscribe for More Information
09:07 EDTACADACADIA initiated with a Buy at Aegis
Subscribe for More Information
07:24 EDTORCLRentrak weakness a buying opportunity, says Brean Capital
Subscribe for More Information
August 21, 2015
17:28 EDTBXBlackstone acquires majority stake in Stearns Holdings
Subscribe for More Information
16:38 EDTACADACADIA unit manufacturing agreement with BASF Pharma
On August 17, our Swiss subsidiary, ACADIA Pharmaceuticals GmbH, entered into a co-operation agreement and product schedule, collectively referred to as the manufacturing agreement, with BASF Pharma SA, or BASF. Under the manufacturing agreement, BASF has agreed to manufacture and supply pimavanserin tartrate, the active pharmaceutical ingredient of NUPLAZID, for commercial use. The term of the manufacturing agreement extends through December 31, 2020 and will automatically renew for subsequent one year terms unless either party provides timely notice of its intent not to renew, or unless the manufacturing agreement is terminated earlier pursuant to its terms.
16:01 EDTHPQOptions Update; August 21, 2015
Subscribe for More Information
12:43 EDTHPQJim Chanos says still long Apple, short HP
Subscribe for More Information
12:43 EDTHPQJim Chanos says still short shares of HP
Jim Chanos of Kynikos Associates is speaking on CNBC
12:13 EDTCSCOBrocade soars after Q3 results top estimates
Subscribe for More Information
12:04 EDTHPQOn The Fly: Top stock stories at midday
Subscribe for More Information
10:37 EDTHPQAnalysts upbeat on HP ahead of split after earnings beat
Subscribe for More Information
09:22 EDTHPQHP CEO says both companies will have over 50% shareholder return
Subscribe for More Information
07:47 EDTHPQHP should be bought at current levels, says Bernstein
Subscribe for More Information
07:43 EDTHPQHP risk/reward remains favorable, says UBS
Subscribe for More Information
07:32 EDTHPQHP guidance will likely leave stock flattish, says Brean Capital
Brean Capital noted HP beat Q2 earnings estimates but believes its guidance will likely leave the stock flattish. The firm expects ongoing PC consolidation, continued cost savings, and for HP to gain incremental traction in its go-forward Enterprises solutions and Services strategy. Brean Capital reiterated its Buy rating and $45 price target on HP shares.
07:26 EDTHPQHP results 'a net positive,' says Stifel
Subscribe for More Information
07:16 EDTHPQHP didn't deliver bad news for first time in several quarters, says Citi
Subscribe for More Information
06:49 EDTHPQHP enterprise portfolio being underappreciated, says Deutsche Bank
Deutsche Bank analyst Sherri Scribner says HP's Q3 results beat expectations while a shift in some earnings into the quarter from Q4 drove "modestly disappointing" guidance. While PCs are weak, HP's Enterprise Group "significantly outperformed expectations," Scribner tells investors in a post-earnings research note. The analyst believes the company's enterprise portfolio is being underappreciated by investors and that the upcoming split should be a positive for shares. She views HP's valuation as compelling and keeps a Buy rating on the stock with a $45 price target.
06:01 EDTHPQABI Research: Portable PC sales to remain flat in 2015, DigiTimes says
Subscribe for More Information
05:51 EDTHPQHP implied volatility of 40 at upper end of index
Subscribe for More Information
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use